- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Adents and Microsoft Introduce NovaTrack Supply Chain Platform
Adents, a serialization and track and trace solutions provider, in collaboration with Microsoft, announced the development of Adents NovaTrack, a new unit-level product track and trace platform using blockchain and AI technologies.
Adents NovaTrack’s foundation includes:
- A “Blockchain as a service” approach for supply chain participants to either run blockchain nodes on premises or via the Cloud.
- Embedded security features, including consortium blockchain mechanisms such as identity management, PKI, and encryption.
- Artificial Intelligence via Microsoft Machine Learning and Business Intelligence Services to collect and analyze data to transform data into actionable business insight.
- Communication standards compliance for various industries, including pharma and other sectors.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
